Galectin Therapeutics
GALT
GALT
60 hedge funds and large institutions have $12M invested in Galectin Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
21% less capital invested
Capital invested by funds: $15.2M → $12M (-$3.14M)
Holders
60
Holding in Top 10
–
Calls
$450K
Puts
$275K
Top Buyers
| 1 | +$38K | |
| 2 | +$34K | |
| 3 | +$29.7K | |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$28K |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1K |
Top Sellers
| 1 | -$144K | |
| 2 | -$109K | |
| 3 | -$90K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$48K |
| 5 |
Morgan Stanley
New York
|
-$47.9K |